While IRBs are hopeful that the changing policies will make it easier to identify unanticipated, serious side effects, more empirical evidence is needed to ensure that this new guidance does not harm patient safety.
Ms. Angelotta is a project coordinator in Dr. Bennett’s office. Dr. Dorr is assistant professor of medical informatics and clinical epidemiology, Oregon Health & Science University. Dr. Bennett is professor of medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine; co-leader, Cancer Control Program, Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and associate director, Midwest Center for Health Services & Policy Research, Jesse Brown VA Medical Center-Lakeside CBOC.